Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct;64(10):2784-2797.
doi: 10.1007/s10620-019-05621-7. Epub 2019 Apr 29.

Content Validity and Reliability of a Self-Report Measure of Medication Nonadherence in Hepatitis C Treatment

Corrine I Voils  1   2 , Heather A King  3   4   5 , Carolyn T Thorpe  6   7 , Dan V Blalock  3   8 , Ian M Kronish  9 , Bryce B Reeve  4 , Colleen Boatright  3 , Ziad F Gellad  3   10
Affiliations

Content Validity and Reliability of a Self-Report Measure of Medication Nonadherence in Hepatitis C Treatment

Corrine I Voils et al. Dig Dis Sci. 2019 Oct.

Abstract

Background: Nonadherence to direct-acting agents (DAAs) for hepatitis C (HCV) decreases viral response. To measure nonadherence to DAAs, a reliable, valid, and easily implemented method is needed.

Aims: The goals of this study were to refine a previously validated (in patients with hypertension) self-report measure of extent of nonadherence and reasons for nonadherence in the context of DAAs and to obtain initial evidence of content validity and reliability.

Methods: Phase I involved two focus groups with patients with HCV (n = 12) and one focus group with prescribers of HCV medications (n = 6) to establish content validity of reasons for nonadherence. Subsequent cognitive interviews with patients (n = 11) were conducted to refine items. Phase II was a prospective cohort study involving weekly administration of the refined measure by telephone to patients (n = 75) who are prescribed DAAs to evaluate reliability and consistency with viral response.

Results: In the cohort study, internal consistency ranged from acceptable (α = .69) to very high (α = 1.00) across time points and was quite high on average (α = .91). Across the 75 participants, there were 895 measurement occasions; of those, nonadherence was reported on only 27 occasions (3%), all of which occurred in the first 12 weeks. These 27 occasions represented 19 (26%) different individuals. At 12 weeks, 1 (1%) of patients had a detectable HCV viral load; at 12-24 weeks posttreatment, 4 (5%) had a sustained viral response. Nonadherent patients reported an average of 1.41 reasons for nonadherence.

Conclusions: This multi-method study established content validity of reasons for nonadherence and reliability of extent of nonadherence. High rates of adherence and viral response were consistent with previous studies using other nonadherence measurement methods.

Keywords: Adherence; Cognitive interviews; Content validity; Focus groups; Psychometrics; Qualitative research.

PubMed Disclaimer

References

    1. Clinicoecon Outcomes Res. 2015 Dec 17;7:637-42 - PubMed
    1. Med Decis Making. 2007 Sep-Oct;27(5):672-80 - PubMed
    1. Qual Health Res. 2005 Nov;15(9):1277-88 - PubMed
    1. Health Psychol. 2018 Nov;37(11):1006-1014 - PubMed
    1. Hepatology. 2013 Jun;57(6):2164-70 - PubMed

Publication types

LinkOut - more resources